Teva’s US antitrust dispute with Corcept, Optime set for trial in 2027
Teva Pharmaceuticals received pushback on its suggested trial date of June 2026 for its pharmaceutical antitrust lawsuit against Corcept Therapeutics and Optime Care, with a US judge calling the recommendation “a...To view the full article, register now.
Already a subscriber? Click here to view full article